Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Fraune

Showing results (11-20 of 138) with videos related to

Pageof 14
Sort By:
Clinical Epigenetics|October 24, 2019
Random forest-based modelling to detect biomarkers for prostate cancer progressionReka Toth, Heiko Schiffmann, Claudia Hube-Magg, et al.
Virchows Archiv : an International Journal of Pathology|December 8, 2019
High homogeneity of mismatch repair deficiency in advanced prostate cancerChristoph Fraune, Ronald Simon, Doris Höflmayer, et al.
Annals of Translational Medicine|March 12, 2021
Y-chromosome loss is frequent in male renal tumorsFranziska Büscheck, Christoph Fraune, Seyedehmina Garmestani, et al.
Urologic Oncology|February 19, 2020
MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor massChristoph Fraune, Ronald Simon, Claudia Hube-Magg, et al.
Oncotarget|February 21, 2020
Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypesFranziska Büscheck, Christoph Fraune, Ronald Simon, et al.
Lung Cancer (Auckland, N.Z.)|January 14, 2026
Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung CancerNina Schraps, Martin Reck, Birgit Hantzsch-Kuhn, et al.
Translational Andrology and Urology|April 14, 2021
Mismatch repair deficiency occurs very rarely in seminomasDavid Dum, Stefan Steurer, Ronald Simon, et al.
Translational Lung Cancer Research|December 10, 2025
High GLUT1 protein expression is associated with unfavorable tumor features and poor prognosis in non-small cell lung cancerBirgit Hantzsch-Kuhn, Nina Schraps, Martin Reck, et al.
Neuroendocrinology|December 6, 2022
Cancer-Associated Fibroblasts Induce Proliferation and Therapeutic Resistance to Everolimus in Neuroendocrine Tumors through STAT3 ActivationTania Amin, Fabrice Viol, Jenny Krause, et al.
World Journal of Urology|April 19, 2020
High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinomaTill Eichenauer, Luca Simmendinger, Christoph Fraune, et al.
Pageof 14

Showing results (11-20 of 138) with videos related to

Sort By:
Pageof 14
Clinical Epigenetics|October 24, 2019
Random forest-based modelling to detect biomarkers for prostate cancer progressionReka Toth, Heiko Schiffmann, Claudia Hube-Magg, et al.
Virchows Archiv : an International Journal of Pathology|December 8, 2019
High homogeneity of mismatch repair deficiency in advanced prostate cancerChristoph Fraune, Ronald Simon, Doris Höflmayer, et al.
Annals of Translational Medicine|March 12, 2021
Y-chromosome loss is frequent in male renal tumorsFranziska Büscheck, Christoph Fraune, Seyedehmina Garmestani, et al.
Urologic Oncology|February 19, 2020
MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor massChristoph Fraune, Ronald Simon, Claudia Hube-Magg, et al.
Oncotarget|February 21, 2020
Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypesFranziska Büscheck, Christoph Fraune, Ronald Simon, et al.
Lung Cancer (Auckland, N.Z.)|January 14, 2026
Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung CancerNina Schraps, Martin Reck, Birgit Hantzsch-Kuhn, et al.
Translational Andrology and Urology|April 14, 2021
Mismatch repair deficiency occurs very rarely in seminomasDavid Dum, Stefan Steurer, Ronald Simon, et al.
Translational Lung Cancer Research|December 10, 2025
High GLUT1 protein expression is associated with unfavorable tumor features and poor prognosis in non-small cell lung cancerBirgit Hantzsch-Kuhn, Nina Schraps, Martin Reck, et al.
Neuroendocrinology|December 6, 2022
Cancer-Associated Fibroblasts Induce Proliferation and Therapeutic Resistance to Everolimus in Neuroendocrine Tumors through STAT3 ActivationTania Amin, Fabrice Viol, Jenny Krause, et al.
World Journal of Urology|April 19, 2020
High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinomaTill Eichenauer, Luca Simmendinger, Christoph Fraune, et al.
Pageof 14